Inclisiran reduces LDL-cholesterol independent of genotype in subjects with heterozygous familial hypercholesterolaemia. (December 2020) - Raal, F.J.; Kallend, D.; Ray, K.K.; Turner, T.A.; Koenig, W.; Wright, R.S.; Wijngaard, P.L.; Curcio, D.; Jaros, M.J.; Leiter, L.A.; Landmesser, U.; Kastelein, J.J.